Send us a text Why are billions of people still invisible in genomic research—and what does that mean for the future of precision medicine? In this episode, I sit down with Victor Angel Mosti, founder and CEO of Omica.Ai, for one of the most insightful conversations I’ve recorded about data equity and building ethical, community-centered AI. Victor shares not only his personal cancer story but also the staggering truth: Hispanic and Latino populations make up less than 1% of genomic datasets....
All content for Digital Pathology Podcast is the property of Aleksandra Zuraw, DVM, PhD and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text Why are billions of people still invisible in genomic research—and what does that mean for the future of precision medicine? In this episode, I sit down with Victor Angel Mosti, founder and CEO of Omica.Ai, for one of the most insightful conversations I’ve recorded about data equity and building ethical, community-centered AI. Victor shares not only his personal cancer story but also the staggering truth: Hispanic and Latino populations make up less than 1% of genomic datasets....
155: AI Pathology & Genomics_ A New Benchmark for Predicting Gene Mutations
Digital Pathology Podcast
23 minutes
3 months ago
155: AI Pathology & Genomics_ A New Benchmark for Predicting Gene Mutations
Send us a text AI Pathology & Genomics: A New Benchmark for Predicting Gene Mutations If you still think visual quantification is “good enough” in pathology, think again. In this 27th episode of DigiPath Digest, I break down four transformative abstracts that show how AI is shifting our diagnostic landscape—from breast cancer segmentation to fibrosis assessment, and all the way to spatial immunology and the evolving immunoscore. If you’re still relying on manual scoring, static staging s...
Digital Pathology Podcast
Send us a text Why are billions of people still invisible in genomic research—and what does that mean for the future of precision medicine? In this episode, I sit down with Victor Angel Mosti, founder and CEO of Omica.Ai, for one of the most insightful conversations I’ve recorded about data equity and building ethical, community-centered AI. Victor shares not only his personal cancer story but also the staggering truth: Hispanic and Latino populations make up less than 1% of genomic datasets....
